Celebrex Sales Data

Rank 21 Current sales rank, all
U.S. Pharmaceuticals.

Last updated: February 2014 (updated quarterly).
The following data shows Celebrex U.S. retail sales in Q4 2013 compared to previous quarters.

Date Range Sales Rank Sales ($000) Units (000)
Q4 2013 21 5.23% 1.71%
Q3 2013 21 (1) 3.46% -9.50%
Q2 2013 22 2.85% 2.28%
Q1 2013 22 2.47% -4.90%
Q4 2012 22 2.61% 2.41%
Q3 2012 22 (9) 12.77% 3.70%
Q2 2012 31 (1) 1.43% 2.25%
Q1 2012 32 1.08% -5.42%
Q4 2011 32 (2) 1.12% 1.47%
Q3 2011 30 (2) -4.82% -4.32%
Q2 2011 28 (1) 1.25% 2.01%
Q1 2011 29

* Units refer to the number of packages sold.

Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.

Related News

DateArticle
March 21, 2014Doctors Often Comply When Patients Ask for Advertised Drugs: Study
September 28, 2011Some Pain Meds Riskier for Cardiac Patients Than Others, Study Suggests
November 29, 2010Celebrex Shows Potential in Preventing Some Skin Cancers: Study
January 8, 2010Celebrex Might Thwart Inherited Skin Cancers
November 24, 2008Study Calls for Greater Scrutiny of 'Off-Label' Drug Use
October 9, 2008NSAIDs Might Lower Breast Cancer Risk
May 16, 2008Celebrex Shows Benefit In First-of-Its-Kind Lung Cancer Chemoprevention Trial

Learn about treatments for OA knee pain to help you stay active. Watch Video

Close
Hide
(web5)